文章核心观点 - PACS Group, Inc. 面临证券集体诉讼，指控其在2024年4月11日的首次公开募股（IPO）及随后的一段时间内，发布了虚假和误导性的声明，未能披露公司业务、运营和前景的重大不利事实 [1][3] 诉讼背景 - 诉讼针对PACS Group, Inc.，涉及在2024年4月11日IPO期间购买或以其他方式获得PACS普通股或证券的投资者，以及在2024年4月11日至2024年11月5日期间购买证券的投资者 [1] - 诉讼的主要原告截止日期为2025年1月13日 [1] 被告的指控 - 被告被指控在注册声明和整个集体诉讼期间，发布了虚假和误导性的声明，未能披露以下事实： 1) PACS参与了一项提交虚假Medicare索赔的计划，该计划在2020年至2023年间推动了PACS超过100%的运营和净收入 [3] 2) 公司参与了一项计划，向Medicare计费数千次不必要的呼吸和感觉整合疗法 [3] 3) PACS参与了一项伪造与执照和员工相关的文件的计划 [3] 4) 由于上述行为，被告关于公司业务、运营和前景的正面声明具有实质性的误导性或缺乏合理依据 [3] 主要原告流程 - PACS投资者可以在2025年1月13日之前，通过Kessler Topaz Meltzer & Check, LLP或其他法律顾问寻求被任命为集体诉讼的主要原告代表，或者选择不参与并保持缺席的集体成员身份 [4] - 主要原告通常是具有最大财务利益且适合代表所有集体成员的投资者或投资者小组 [4] 联系信息 - 投资者可以通过点击链接或访问网站 https://www.ktmc.com/new-cases/pacs-groupinc?utm_source=PR&utm_medium=link&utm_campaign=pacs&mktm=r 获取更多信息，或联系律师Jonathan Naji, Esq.，电话：(484) 270-1453，邮箱：[email protected] [2][6]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PACS Group To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in PACS Group between (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's April 11, 2024 initial public offering ("IPO" or the "Offering"); and/or  (b) all pe ...

文章核心观点 - 领先证券法律公司Bleichmar Fonti & Auld LLP宣布对PACS Group及其部分高管提起诉讼，指控其违反联邦证券法，投资者可通过指定链接获取更多信息 [1] 诉讼相关情况 - 投资者需在2025年1月13日前请求法院指定其牵头该案件，诉讼依据1933年《证券法》第11和15条以及1934年《证券交易法》第10（b）和20（a）条代表PACS证券投资者提出索赔，案件正在纽约南区美国地方法院审理 [2] 诉讼原因 - 投诉称PACS是美国最大的专业护理机构运营商之一，其多次向股东表示拥有使护理机构盈利的“扭亏为盈”策略，但实际上该策略是通过非法获取数千名患者的医疗保险福利来推动的 [3] - 2024年11月4日，投资研究公司Hindenburg Research发布报告，经5个月调查后指控PACS滥用新冠疫情时代的豁免政策，不当获取全国设施数千名患者的专业护理医疗保险福利，并估计该计划在2020 - 2023年推动了PACS超过100%的运营和净收入，使其在2024年初能以合法增长和盈利的假象进行首次公开募股 [4] - 2024年11月6日，PACS宣布推迟第三季度财报，并表示收到联邦政府关于公司报销和转诊做法的民事调查要求，该消息可能与本周第三方报告有关 [4] 股价影响 - 2024年11月4日，公司股价下跌27.8%，从11月1日收盘价每股42.94美元降至11月4日每股31.01美元；11月6日，股价下跌38.8%，从11月5日收盘价每股29.54美元降至11月6日每股18.09美元 [4] 投资者行动建议 - 若投资者投资了PACS，可能有法律途径，可向该公司提交信息，代理采用风险代理收费，投资者无需承担任何诉讼费用，公司将寻求法院批准潜在费用和开支 [6] - 投资者可通过指定链接提交信息，也可联系指定人员 [7] 律所情况 - Bleichmar Fonti & Auld LLP是一家领先的国际律师事务所，代表证券集体诉讼和股东诉讼的原告，2023年被ISS SCAS评为前5名原告律师事务所，其律师被Law360评为原告律师界巨头，被汤森路透评为超级律师 [7] - 该律所近期显著成果包括从特斯拉董事会追回超9亿美元价值（待法院批准），从梯瓦制药工业有限公司追回4.2亿美元 [8]

RADNOR, Pa., Dec. 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against PACS Group, Inc. (“PACS”) (NYSE: PACS). The lawsuit is brought on behalf of investors who purchased or otherwise acquired PACS: 1) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registrati ...

NEW YORK, Dec. 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PACS Group, Inc. (NYSE: PACS).Shareholders who purchased shares of PACS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/pacs-group-inc-loss-submission-form/?id=114730&from=4CLASS PERIOD: This lawsuit is on behal ...

NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of PACS Group, Inc. (NYSE: PACS). Shareholders who purchased shares of PACS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/pacs-group-inc-loss-submission-form/?id=114513&from=3 CLASS PERIOD: This lawsuit is ...

NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against PACS Group, Inc. (NYSE: PACS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/pacs-group-inc. Investors have until January 13, 2025, to ask the Court to be appointed to lead t ...

PHILADELPHIA, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against PACS Group, Inc. (“PACS” or the “Company”) (NYSE: PACS) on behalf of purchasers of PACS securities between April 8, 2024 through November 21, 2024, inclusive (the “Class Period”). Investor Deadline: Investors who purchased or acquired PACS securities during the Class Period may, no later than JANUARY 13, 2025, seek to be appointed as a lead plaintiff representati ...

SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired PACS Group, Inc. (NYSE: PACS) (a) common stock in connection with the Company's April 11, 2024 initial public offering ("IPO"), or (b) securities between April 11, 2024 and November 5, 2024. PACS Group, through its subsidiaries, operates senior care facilities, skilled nursing facilities, and assisted living facilities in the Unit ...

RADNOR, Pa., Dec. 3, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against PACS Group, Inc. ("PACS") (NYSE: PACS). The lawsuit is brought on behalf of investors who purchased or otherwise acquired PACS: 1) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with PACS' April 11, 2024 initial public of ...